Fulvenat 250mg Injection
Marketer
Natco Pharma Ltd
Salt Composition
Fulvestrant (250mg)
Overview Fulvenat 250mg Injection
Letrozole 250mg Injection is an anti-estrogen medication employed in postmenopausal women with breast cancer. Its mechanism involves regulating estrogen levels to inhibit cancer cell proliferation. Administered intramuscularly under medical guidance, the dosage and frequency are determined by the treating physician based on individual needs and response. Treatment duration adheres to the prescribed regimen. Commonly reported adverse effects include injection site reactions, headache, nausea, vomiting, and allergic responses. Any concerning symptoms should be promptly reported to your doctor, who can explore mitigating strategies. Prior to commencing treatment, inform your physician of any pre-existing kidney or liver conditions, bleeding disorders, anticoagulant use, and all other medications being taken, as potential interactions may affect efficacy or alter the drug's action. Disclose current pregnancy, pregnancy plans, or breastfeeding status.
Uses of Fulvenat 250mg Injection
Malignant breast tumor
Major Benefits of Fulvenat 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Fulvenat 250mg Injection:
- Headache
- Vomiting
- Weakness
- Allergic reaction
- Nausea
- Injection site reaction
- Urinary tract infection
- Diarrhea
How to use Fulvenat 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Fulvenat 250mg Injection works:
Fulvestrant 250mg injection inhibits estrogen's effects on breast cancer cells, potentially suppressing or halting the proliferation of estrogen-receptor-positive breast cancers.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Fulvenat 250mg Injection concurrently with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Fulvenat 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Fulvenat 250mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingSAFE
Driving ability is typically unaffected by Fulvenat 250mg Injection.
KidneyCAUTION
Administering Fulvenat 250mg Injection to individuals with severe kidney impairment requires careful consideration. A modified dosage of Fulvenat 250mg Injection might be necessary; physician consultation is advised. Data regarding Fulvenat 250mg Injection use in such patients is limited. Dosage alteration is not suggested for patients exhibiting mild or moderate kidney dysfunction.
LiverCAUTION
Patients with hepatic impairment should use Fulvenat 250mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Fulvenat 250mg Injection :
Should you forget a Fulvenat 250mg Injection, seek your physician's advice.
Facts to Know About Fulvenat 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Estrogen Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Category | Estrogen receptor blocker |
3,018 People bought this recently